[Hepatotoxicity of drugs commonly used in rheumatology].
Abadia
R
R
Jammet
P
P
Christoforov
B
B
Cremer
G A
GA
D000082:Acetaminophen / Q000009:adverse effects; D000700:Analgesics / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000503:physiopathology; D011431:Dextropropoxyphene / Q000009:adverse effects; D005897:Glafenine / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007210:Indoleacetic Acids / Q000009:adverse effects; D010396:Penicillamine / Q000009:adverse effects; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012460:Sulfasalazine / Q000009:adverse effects
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D007210:Indoleacetic Acids; D000082:Acetaminophen; D012460:Sulfasalazine; D005897:Glafenine; D010396:Penicillamine; C017136:clometacin; D011431:Dextropropoxyphene
Hépatotoxicité des médicaments couramment utilisés en rhumatologie.